Drug intelligence / Profile preview

bifidobacterium adolescentis (Lacto-Research)

Development stage: Unknown
Lead developer: LactoResearch
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

*Bifidobacterium adolescentis* is a Gram-positive, anaerobic bacterium and a common member of the human intestinal microbiota. As a probiotic or live biotherapeutic, it is being investigated for its ability to modulate the immune system and inhibit the growth of pathogens. In clinical and preclinical research, it has been studied for its role in suppressing pro-inflammatory *Candida* species in ulcerative colitis and for its potential (though less potent than *B. longum*) in reducing allergic airway inflammation in asthma models via acetate production. It is also a component of multi-strain probiotic formulations developed by companies like LactoResearch for the management of lactose intolerance, where it aids in lactose digestion and the improvement of gastrointestinal symptoms.

Other names: B. adolescentis

Targets

FFAR2

Beyond the preview

Go deeper on bifidobacterium adolescentis (Lacto-Research).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on bifidobacterium adolescentis (Lacto-Research).

Explore the full profile